D
Personalis, Inc. PSNL
$5.16 $0.061.18% NASDAQ
Recommendation
Prev Close
$5.10
Volume
351,652
Avg Vol (90D)
992,733
Market Cap
$450.14M
Dividend & Yield
--
52-Week Range
$1.14 - $7.20
P/E (TTM)
--
EPS (TTM)
-$1.37
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
What is HC Wainwright's Estimate for Personalis Q2 Earnings?
5/13/2025 - MarketBeat
8,160,734 Shares in Personalis, Inc. (NASDAQ:PSNL) Purchased by Lightspeed Management Company L.L.C.
5/12/2025 - Ticker Report
HC Wainwright Boosts Personalis (NASDAQ:PSNL) Price Target to $9.00
5/9/2025 - MarketBeat
Personalis management to meet with Lake Street
5/9/2025 - The Fly
Personalis First Quarter 2025 Earnings: Beats Expectations
5/8/2025 - Simply Wall St
Personalis management to meet with Lake Street
5/8/2025 - The Fly
Bullish Two Hundred Day Moving Average Cross - PSNL
5/7/2025 - Market News Video
Personalis (PSNL) Receives Price Target Boost from Analyst PSNL Stock News
5/7/2025 - GuruFocus
H.C. Wainwright Increases Price Target for Personalis (PSNL) to $9 PSNL Stock News
5/7/2025 - GuruFocus
Personalis price target raised by $1 at H.C. Wainwright, here's why
5/7/2025 - The Fly
Personalis Inc (PSNL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ...
5/7/2025 - GuruFocus
Q1 2025 Personalis Inc Earnings Call Transcript
5/7/2025 - GuruFocus
Personalis (PSNL) Q1 2025 Earnings Reflects Strong Growth in Molecular Tests
5/7/2025 - GuruFocus
Personalis reiterates 2025 revenue guidance of $80M-$90M with focus on MRD testing growth
5/7/2025 - SeekingAlpha.com: All News
Personalis, Inc. (PSNL) Q1 2025 Earnings Call Transcript
5/7/2025 - Seeking Alpha: Transcripts
Personalis, Inc. (PSNL) Q1 2025 Earnings Call Transcript
5/7/2025 - SeekingAlpha
Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates
5/6/2025 - Zacks Investment Research
Personalis Inc (PSNL) Q1 2025 Earnings: EPS of -$0.24 Beats Estimate, Revenue at $13. ...
5/6/2025 - GuruFocus
Personalis Reports First Quarter 2025 Financial Results
5/6/2025 - GuruFocus
Personalis (PSNL) Reports Strong Q1 Revenue and Testing Growth PSNL Stock News
5/6/2025 - GuruFocus
Personalis sees Q2 revenue $19.5M-$20.5M, consensus $19.03M
5/6/2025 - The Fly
Personalis sees FY25 revenue $80M-$90M, consensus $82.7M
5/6/2025 - The Fly
Personalis reports Q1 EPS (18c), consensus (25c)
5/6/2025 - The Fly
Personalis Reports First Quarter 2025 Financial Results
5/6/2025 - Business Wire
Personalis, Inc. (NASDAQ:PSNL) Stocks Shoot Up 37% But Its P/S Still Looks Reasonable
5/6/2025 - Simply Wall St
Income Statement
Total Revenue (TTM)
$84.61M
EBITDA (TTM)
-$57.33M
EBIT (TTM)
-$68.27M
Net Income (TTM)
-$81.28M
Balance Sheet
Total Assets (Q)
$270.27M
Total Debt (Q)
$44.35M
Total Liabilities (Q)
$67.31M
Book Value Per Share (Q)
$2.38
Cash Flow
Cash from Operations (TTM)
-$45.15M
Cash from Investing (TTM)
-$35.07M
Cash from Financing (TTM)
$114.67M
Net Change in Cash (TTM)
$34.43M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.96
7-Day Total Return
24.04%
30-Day Total Return
47.01%
60-Day Total Return
-6.35%
90-Day Total Return
-10.73%
Year to Date Total Return
-17.70%
1-Year Total Return
235.06%
2-Year Total Return
134.55%
3-Year Total Return
2.79%
5-Year Total Return
-52.57%
52-week Low
Jul 01, 2024 - $1.14
52-week High
Aug 16, 2024 - $7.20
Valuation
Market Cap
$450.14M - Small Cap
Enterprise Value
$298.57M
Price/Sales (TTM)
4.39
Price/Book (Q)
2.14
Dividends and Shares
Shares Outstanding
72.88M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.personalis.com
Phone Number
650 752 1300
Address
6600 Dumbarton Circle
Fremont, CA 94555
Country
United States
Year Founded
2011
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy... more
NASDAQ 05/13/2025 2:42PM Eastern Quotes delayed